Search research articles
Contact Us
Filters
Showing results (31-40 of 106) with videos related to
Page
of 11
Sort By:
American Journal of Preventive Cardiology
|
September 5, 2022
GlycA, hsCRP differentially associated with MI, ischemic stroke: In the Dallas Heart Study and Multi-Ethnic Study of Atherosclerosis: GlycA, hsCRP Differentially Associated MI, Stroke
Kayla A Riggs, Parag H Joshi, Amit Khera, et al.
The American Journal of Cardiology
|
March 28, 2025
Increase in Lipoprotein(a) Screening and Utilization at an Urban Academic Medical Center
Willis Wong, Cindy Kao, Ruth Schneider, et al.
JAMA Cardiology
|
October 28, 2020
Value of Coronary Artery Calcium Scanning in Association With the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease
Ezimamaka Ajufo, Colby R Ayers, Rebecca Vigen, et al.
Journal of Medical Case Reports
|
October 24, 2022
Ivabradine toxicity: a case report
Kavisha Singh, Muthukumar R Alagarraju, Carl E Wolf, et al.
Vascular Health and Risk Management
|
April 22, 2014
Current guidelines for high-density lipoprotein cholesterol in therapy and future directions
Bishnu H Subedi, Parag H Joshi, Steven R Jones, et al.
American Journal of Preventive Cardiology
|
February 2, 2026
Clinician-level variation in lipid management for secondary prevention of atherosclerotic cardiovascular disease: Opportunities for practice improvement
Danh Q Nguyen, Jimin Hwang, Anand Rohatgi, et al.
The International Journal of Cardiovascular Imaging
|
November 30, 2011
Demonstration of the Glagov phenomenon in vivo by CT coronary angiography in subjects with elevated Framingham risk
Sarah Rinehart, Zhen Qian, Gustavo Vazquez, et al.
The Lancet. Diabetes & Endocrinology
|
August 6, 2021
Effects of liraglutide on visceral and ectopic fat in adults with overweight and obesity at high cardiovascular risk: a randomised, double-blind, placebo-controlled, clinical trial
Ian J Neeland, Steven P Marso, Colby R Ayers, et al.
Journal of the American College of Cardiology
|
June 4, 2013
High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link?
Omair Yousuf, Bibhu D Mohanty, Seth S Martin, et al.
Journal of the American Heart Association
|
December 2, 2020
Effect of Anacetrapib on Cholesterol Efflux Capacity: A Substudy of the DEFINE Trial
Mark P Metzinger, Suzanne Saldanha, Jaskeerat Gulati, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 106) with videos related to
Sort By:
Page
of 11
American Journal of Preventive Cardiology
|
September 5, 2022
GlycA, hsCRP differentially associated with MI, ischemic stroke: In the Dallas Heart Study and Multi-Ethnic Study of Atherosclerosis: GlycA, hsCRP Differentially Associated MI, Stroke
Kayla A Riggs, Parag H Joshi, Amit Khera, et al.
The American Journal of Cardiology
|
March 28, 2025
Increase in Lipoprotein(a) Screening and Utilization at an Urban Academic Medical Center
Willis Wong, Cindy Kao, Ruth Schneider, et al.
JAMA Cardiology
|
October 28, 2020
Value of Coronary Artery Calcium Scanning in Association With the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease
Ezimamaka Ajufo, Colby R Ayers, Rebecca Vigen, et al.
Journal of Medical Case Reports
|
October 24, 2022
Ivabradine toxicity: a case report
Kavisha Singh, Muthukumar R Alagarraju, Carl E Wolf, et al.
Vascular Health and Risk Management
|
April 22, 2014
Current guidelines for high-density lipoprotein cholesterol in therapy and future directions
Bishnu H Subedi, Parag H Joshi, Steven R Jones, et al.
American Journal of Preventive Cardiology
|
February 2, 2026
Clinician-level variation in lipid management for secondary prevention of atherosclerotic cardiovascular disease: Opportunities for practice improvement
Danh Q Nguyen, Jimin Hwang, Anand Rohatgi, et al.
The International Journal of Cardiovascular Imaging
|
November 30, 2011
Demonstration of the Glagov phenomenon in vivo by CT coronary angiography in subjects with elevated Framingham risk
Sarah Rinehart, Zhen Qian, Gustavo Vazquez, et al.
The Lancet. Diabetes & Endocrinology
|
August 6, 2021
Effects of liraglutide on visceral and ectopic fat in adults with overweight and obesity at high cardiovascular risk: a randomised, double-blind, placebo-controlled, clinical trial
Ian J Neeland, Steven P Marso, Colby R Ayers, et al.
Journal of the American College of Cardiology
|
June 4, 2013
High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link?
Omair Yousuf, Bibhu D Mohanty, Seth S Martin, et al.
Journal of the American Heart Association
|
December 2, 2020
Effect of Anacetrapib on Cholesterol Efflux Capacity: A Substudy of the DEFINE Trial
Mark P Metzinger, Suzanne Saldanha, Jaskeerat Gulati, et al.
Page
of 11